Kenth Ingemar Petersson
Vorsitzender bei AlphaBeta AB
Ursprung des Netzwerks ersten Grades von Kenth Ingemar Petersson
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 39 | |
| Public Company | Pharmaceuticals: Major | 7 | |
BioCrine AB
5
| Subsidiary | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Kenth Ingemar Petersson
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| University of Lund | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Masters Business Admin Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
Atlas Therapeutics AB
 Atlas Therapeutics AB Pharmaceuticals: MajorHealth Technology Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal Chairman Chairman Director/Board Member Director/Board Member Chairman | |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| University of Uppsala | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| A Bioscience Incentive AB | Corporate Officer/Principal Chairman Chairman Director/Board Member Director/Board Member Director/Board Member | ||
| University of Copenhagen | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree | |
| IRLAB THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director/Board Member | |
| SENZAGEN AB | Biotechnology | Founder Director/Board Member Director/Board Member Director/Board Member | |
| BIOINVENT INTERNATIONAL AB | Biotechnology | Founder Investor Relations Contact Chairman Director/Board Member | |
Dako ApS
 Dako ApS Electronic Equipment/InstrumentsElectronic Technology Part of Agilent Technologies, Inc., Dako ApS is a Danish company that designs and manufactures cancer diagnostic systems. The company is based in Glostrup, Denmark. | Electronic Equipment/Instruments | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Sales & Marketing | |
| Stockholm School of Economics | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| Karolinska Institutet | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
| BIOTAGE AB | Medical Specialties | Founder Director/Board Member Sales & Marketing | |
| Amersham Biosciences AB | Corporate Officer/Principal Sales & Marketing Sales & Marketing | ||
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer Sales & Marketing | |
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| University of Stockholm | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Chief Operating Officer | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Founder Director/Board Member Director/Board Member | |
| CELLAVISION AB | Medical Specialties | Director/Board Member Director/Board Member | |
Cellevate AB
 Cellevate AB Miscellaneous Commercial ServicesCommercial Services Cellevate AB is a Swedish biotech company that specializes in developing advanced cell culture systems. The private company is based in Lund, Sweden. The company's patented manufacturing process creates highly porous and consistent networks of nanofibers. Cellevate was founded by Lars Gosta Montelius. | Miscellaneous Commercial Services | Director/Board Member Chief Executive Officer | |
Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt
 Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt Miscellaneous Commercial ServicesCommercial Services Hjärt-Lungfonden Svenska Nationalföreningen mot hjärt is a non-profit organization based in Stockholm, Sweden. and has subsidiaries in Sweden. The organization's main objective is to raise funds for selected Swedish heart and lung research to help people live longer and healthier lives. The Swedish company works together with individuals and companies to collect and distribute funds for heart and lung research. The organization's vision is to create a world free from heart and lung disease. Kärlkramp, which is a temporary reduction of blood flow in the heart's coronary vessels and the main symptom is a squeezing chest pain, is one of the diseases they focus on. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
GE Healthcare AB
 GE Healthcare AB Pharmaceuticals: MajorHealth Technology GE Healthcare AB wholesales and distributes pharmaceutical products. It promotes contrast agents for X-rays, magnetic resonance imaging, ultrasound and radiopharmaceuticals, use to predict and diagnose early-stage diseases. The company was founded on October 21, 1983 and is headquartered in Danderyd, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| CERENO SCIENTIFIC AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ACTIVE BIOTECH AB | Biotechnology | Public Communications Contact Director/Board Member | |
| BIOGAIA AB | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
ApoEx AB
 ApoEx AB Medical DistributorsDistribution Services ApoEx AB offers products and services to healthcare industry. The firm provides services for dentistry, aesthetic surgery and medical care, animal care, and government. The company was founded by Jens-Leo Hubertus Berlips and John Patrick Berlips in 2010 and is headquartered in Stockholm, Sweden. | Medical Distributors | Director/Board Member Director of Finance/CFO | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VIROGATES A/S | Medical Specialties | Founder Chairman | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CMC SPV of 3 April 2017 AB | Director/Board Member Director/Board Member | ||
PainDrainer AB
 PainDrainer AB Packaged SoftwareTechnology Services PainDrainer AB is a Swedish medical technology company that helps people with chronic pain achieve a better quality of life and activity balance. The company is based in Lund, Sweden. The company's app is based on seven categories that have a scientifically proven impact on pain levels. Users can choose what they want to do more of in their lives, and the app helps them achieve their goals. PainDrainer has been shown to have a scientifically documented effect in many clinical studies and is a CE-marked medical technical app. The CEO of the company is Erik Frick. | Packaged Software | Chairman Director/Board Member | |
| WNTRESEARCH AB | Pharmaceuticals: Other | Director/Board Member Chief Executive Officer | |
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Investment Managers | Consultant / Advisor Private Equity Investor | |
| Wallac Oy | Corporate Officer/Principal Corporate Officer/Principal | ||
| ONCOPEPTIDES AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Investor Relations Contact | |
| STORYTEL AB | Publishing: Books/Magazines | Director/Board Member Director/Board Member | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Handelshögskolan i Göteborg | College/University | Masters Business Admin Graduate Degree | |
| Royal Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree | |
Gradientech AB
 Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Biotechnology | Director/Board Member Director/Board Member | |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Founder Director/Board Member | |
Atlas Antibodies AB
 Atlas Antibodies AB BiotechnologyHealth Technology Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden. | Biotechnology | Founder Director/Board Member |
Statistik
International
| Schweden | 42 |
| Dänemark | 8 |
| Vereinigtes Königreich | 2 |
| Finnland | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 10 |
| Commercial Services | 7 |
| Finance | 3 |
| Electronic Technology | 2 |
Operativ
| Director/Board Member | 352 |
| Corporate Officer/Principal | 114 |
| Chairman | 85 |
| Chief Executive Officer | 66 |
| Independent Dir/Board Member | 66 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Kenth Ingemar Petersson
- Unternehmensverbindungen
